A novel medulloblastoma oncogene, OTX2, correlates with severe anaplasia and patient survival
Publication
, Conference
Adamson, DC; Di, CH; Shi, Q; McLendon, RE; Bigner, DD; Yan, H
Published in: JOURNAL OF NEUROSURGERY
2006
Duke Scholars
Published In
JOURNAL OF NEUROSURGERY
ISSN
0022-3085
Publication Date
2006
Volume
104
Issue
4
Start / End Page
A636 / A636
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Adamson, D. C., Di, C. H., Shi, Q., McLendon, R. E., Bigner, D. D., & Yan, H. (2006). A novel medulloblastoma oncogene, OTX2, correlates with severe anaplasia and patient survival. In JOURNAL OF NEUROSURGERY (Vol. 104, pp. A636–A636).
Adamson, D. C., C. H. Di, Q. Shi, R. E. McLendon, D. D. Bigner, and H. Yan. “A novel medulloblastoma oncogene, OTX2, correlates with severe anaplasia and patient survival.” In JOURNAL OF NEUROSURGERY, 104:A636–A636, 2006.
Adamson DC, Di CH, Shi Q, McLendon RE, Bigner DD, Yan H. A novel medulloblastoma oncogene, OTX2, correlates with severe anaplasia and patient survival. In: JOURNAL OF NEUROSURGERY. 2006. p. A636–A636.
Adamson, D. C., et al. “A novel medulloblastoma oncogene, OTX2, correlates with severe anaplasia and patient survival.” JOURNAL OF NEUROSURGERY, vol. 104, no. 4, 2006, pp. A636–A636.
Adamson DC, Di CH, Shi Q, McLendon RE, Bigner DD, Yan H. A novel medulloblastoma oncogene, OTX2, correlates with severe anaplasia and patient survival. JOURNAL OF NEUROSURGERY. 2006. p. A636–A636.
Published In
JOURNAL OF NEUROSURGERY
ISSN
0022-3085
Publication Date
2006
Volume
104
Issue
4
Start / End Page
A636 / A636
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences